Satellos Bioscience Stock Quote MSCL - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.83

Bid

0.82

Ask

0.83

Volume

0.00 Day's Range 0.00

0.38 52 Week Range 1.32

Market Cap

93.617M

Previous Close

0.83

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

147,427

Shares Outstanding

112,792,000

Dividend Yield

PE Ratio

-5.89

Earnings Per Share (EPS)

-0.14

Revenue

Net Profit

-15.89M

Sector

Coml Physical, Biologcl Resh

Industry

Pharmaceutical Preparations

Website

www.satellos.com

Headquarters

Toronto, Ontario, Can

Founded

2007

Satellos Bioscience Inc is listed in the Coml Physical, Biologcl Resh sector of the Toronto Stock Exchange with ticker MSCL. The last closing price for Satellos Bioscience was $0.83. Over the last year, Satellos Bioscience shares have traded in a share price range of $ 0.38 to $ 1.32.

Satellos Bioscience currently has 112,792,000 shares outstanding. The market capitalization of Satellos Bioscience is $93.62 million. Satellos Bioscience has a price to earnings ratio (PE ratio) of -5.89.

L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - MSCL

L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - MSCL Canada NewsWire TORONTO, le 17 déc. 2024 TORONTO, le 17 déc. 2024 /CNW/...

Canadian Investment Regulatory Organization Trade Resumption - MSCL

Canadian Investment Regulatory Organization Trade Resumption - MSCL Canada NewsWire TORONTO, Dec. 17, 2024 TORONTO, Dec. 17, 2024 /CNW/ - Trading resumes in: Company: Satellos Bioscience...

Suspension de la négociation par l'Organisme canadien de réglementation des investissements - MSCL

Suspension de la négociation par l'Organisme canadien de réglementation des investissements - MSCL Canada NewsWire TORONTO, le 16 déc. 2024 TORONTO, le 16 déc. 2024 /CNW/...

Canadian Investment Regulatory Organization Trading Halt - MSCL

Canadian Investment Regulatory Organization Trading Halt - MSCL Canada NewsWire TORONTO, Dec. 16, 2024 TORONTO, Dec. 16, 2024 /CNW/ - The following issues have been halted by CIRO: Company:...

Satellos Announces First Participant with Duchenne Muscular Dystrophy Dosed in the Phase 1b Clinical Trial of SAT-3247

- Marks successful completion of full enrollment of SAD cohorts and the first two MAD cohorts in the healthy volunteer study - Up to 10 adult participants with genetically confirmed Duchenne...

Satellos to Participate in Oppenheimer Movers in Rare Disease Summit

Satellos Bioscience Inc. (TSX:MSCL, OTCQB:MSCLF) (“Satellos”), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and...

Satellos to Participate in Duchenne KOL Investor Webinar on December 4, 2024

Satellos Bioscience Inc. (TSX:MSCL, OTCQB:MSCLF) ("Satellos" or the "Company"), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle...

Satellos Appoints Stephanie Brown to Board of Directors

Satellos Bioscience Inc. (TSX: MSCL) (OTCQB: MSCLF) (“Satellos” or the “Company”), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle...

Satellos Reports Q3 2024 Financial Results and Provides Clinical Update

- Completed enrollment for SAT-3247 in Duchenne muscular dystrophy (DMD) in the first three (of five) single-ascending dose (SAD) cohorts with no safety concerns and initiated enrollment of first...

Satellos to Participate in November 2024 Investor Conferences

Satellos Bioscience Inc. (“Satellos” or the “Company”) (TSX: MSCL) (OTCQB: MSCLF), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.02	-2.35294117647	0.85	0.86	0.82	18314	0.83223294	CS
4	0	0	0.83	0.89	0.81	108217	0.86499106	CS
12	0.08	10.6666666667	0.75	1.32	0.67	147427	0.88105912	CS
26	0.335	67.6767676768	0.495	1.32	0.45	120964	0.75466035	CS
52	0.21	33.8709677419	0.62	1.32	0.38	95508	0.68848996	CS
156	0.21	33.8709677419	0.62	1.32	0.38	95508	0.68848996	CS
260	0.21	33.8709677419	0.62	1.32	0.38	95508	0.68848996	CS

MSCL - Frequently Asked Questions (FAQ)

What is the current Satellos Bioscience share price?

The current share price of Satellos Bioscience is $ 0.83

How many Satellos Bioscience shares are in issue?

Satellos Bioscience has 112,792,000 shares in issue

What is the market cap of Satellos Bioscience?

The market capitalisation of Satellos Bioscience is CAD 93.62M

What is the 1 year trading range for Satellos Bioscience share price?

Satellos Bioscience has traded in the range of $ 0.38 to $ 1.32 during the past year

What is the PE ratio of Satellos Bioscience?

The price to earnings ratio of Satellos Bioscience is -5.89

What is the reporting currency for Satellos Bioscience?

Satellos Bioscience reports financial results in CAD

What is the latest annual profit for Satellos Bioscience?

The latest annual profit of Satellos Bioscience is CAD -15.89M

What is the registered address of Satellos Bioscience?

The registered address for Satellos Bioscience is 79 WELLINGTON STREET WEST, 33RD FLOOR, TORONTO, ONTARIO, M5K 1N2

What is the Satellos Bioscience website address?

The website address for Satellos Bioscience is www.satellos.com

Which industry sector does Satellos Bioscience operate in?

Satellos Bioscience operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
134AUPraise Inc	0.00 (0.00%)	0
1332Nissui Corporation	0.00 (0.00%)	0
132AIN Holdings Co Ltd	0.00 (0.00%)	0
131ACCN Group Corp	0.00 (0.00%)	0
130AVeritas In Silico Inc	0.00 (0.00%)	0
134AUPraise Inc	0.00 (0.00%)	0
1332Nissui Corporation	0.00 (0.00%)	0
132AIN Holdings Co Ltd	0.00 (0.00%)	0
131ACCN Group Corp	0.00 (0.00%)	0
130AVeritas In Silico Inc	0.00 (0.00%)	0
134AUPraise Inc	0.00 (0.00%)	0
1332Nissui Corporation	0.00 (0.00%)	0
132AIN Holdings Co Ltd	0.00 (0.00%)	0
131ACCN Group Corp	0.00 (0.00%)	0
130AVeritas In Silico Inc	0.00 (0.00%)	0